✦ LIBER ✦

Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693

✍ Scribed by Rakesh Kumar; Stephen J Blakemore; Catherine E Ellis; Emanuel F Petricoin; Dexter Pratt; Michael Macoritto; Andrea L Matthews; Joseph J Loureiro; Keith Elliston

Book ID: 115003337
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 635 KB
Volume: 11
Category: Article
ISSN: 1471-2164
DOI: 10.1186/1471-2164-11-419

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of 4-(2-(4-Amino-1,2,5-ox

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase

✍ Rhodes, Nelson; Leber, Jack D.; Clark, Tammy J.; Keenan, Richard M.; Lafrance, L 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 886 KB

62 Pre-clinical evaluation of LYS6KAKT1,

62 Pre-clinical evaluation of LYS6KAKT1, a novel, highly selective, orally bioavailable dual inhibitor of p70 S6 Kinase and AKT currently in phase I clinical trials for cancer

✍ S. Geeganage; L. Sams; S. Joseph; T. Shepherd; R. Dally; L. Brail; T. Wang; A. C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB